<DOC>
	<DOCNO>NCT03076502</DOCNO>
	<brief_summary>This study aim evaluate role ct-DNA , PVT1 reactive oxygen specie ( ROS ) biomarkers diagnosis , treatment recurrence monitor gastrointestinal hepatobiliary pancreatic cancer .</brief_summary>
	<brief_title>The Role ctDNA , PVT1 ROS Diagnosis Treatment Gastrointestinal Hepatobiliary Pancreatic Cancer</brief_title>
	<detailed_description>Epidemiological survey show significant increase trend gastrointestinal hepatobiliary pancreatic cancer recent year . How make early diagnosis gastrointestinal liver cancer well prognostic evaluation efficacy monitoring , become hotspot . `` liquid biopsy '' , meant detect cancer sequence DNA drop person 's blood . It may detect cancer early , even symptom arise , cell blood circulation . ct-DNA cancer patient often bear similar genetic epigenetic feature related tumor DNA . There evidence ct-DNA originate tumoral tissue . Besides , ct-DNA easily isolated circulation body fluids patient , make promise candidate non-invasive biomarker cancer . It known level cellular ROS correlate aggressiveness tumour cell prognosis patient . Cancer cell increase endogenous ROS stress sensitive anticancer agent high level ROS generate chemotherapeutic agent induce cell death . Hence , ROS level chemotherapy cancer cell early indicator treatment efficacy , potential shed new light choice cancer therapy . This study aim evaluate role ct-DNA ROS biomarkers diagnosis , treatment recurrence monitor gastrointestinal hepatobiliary pancreatic cancer .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Digestive System Neoplasms</mesh_term>
	<criteria>Patients suspect gastrointestinal hepatobiliary pancreatic cancer Age 18 80 year No serious organic mental illness ; Pregnancy No pathologic result Suffering malignancy time .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>ctDNA</keyword>
	<keyword>Gastrointestinal Cancer</keyword>
	<keyword>ROS</keyword>
	<keyword>Hepatobiliary Pancreatic Cancer</keyword>
</DOC>